research

Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cells

Authors
Publication date
1 January 2017
Publisher
Digital Commons@Becker
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Digital Commons@Becker

      redirect
      oaioai:digitalcommons.wustl.edu:o...
      Last time updated on 14/08/2017